Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the effectiveness of ivermectin for the treatment of COVID-19; and what plans they have to permit General Practitioners and pharmacies to supply ivermectin to the public for the treatment of that disease.

Ivermectin is not a licensed treatment for COVID-19 and evidence from clinical trials of ivermectin as a treatment for COVID-19 is inconclusive at this stage. We have included ivermectin in the United Kingdom (UK) Government funded PRINCIPLE clinical trial to help generate conclusive data on its effectiveness in treating patients with COVID-19 who have not been hospitalised. We will continue to monitor the data from this trial and other trials completed worldwide, to expand the evidence base for Ivermectin. There are no plans to permit healthcare professionals to supply Ivermectin to UK patients for treatment of COVID-19 unless the Medicines and Healthcare products Regulatory Agency approves ivermectin as a licensed treatment for COVID-19 in future.